{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-020057","form_type":"8-K","ticker":"INTS","cik":"0001567264","company_name":"INTENSITY THERAPEUTICS, INC.","filed_at":"2025-04-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.808922+00:00","generated_at":"2026-05-23T05:51:04.907735+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Intensity Therapeutics prices $2.35M public offering of common stock and warrants","bullets":["3,133,333 shares and two series of warrants priced at $0.75 per unit; gross proceeds ~$2.35M.","Net proceeds of ~$1.9M after 7% placement agent fee and expenses.","Series B-1 warrants ($0.85 exercise, 5-yr term) and B-2 warrants ($0.85, 18-mo term).","Proceeds for INVINCIBLE-4 patient enrollment, INVINCIBLE-3 treatment, and working capital.","Offering expected to close April 28, 2025; A.G.P. and Brookline Capital Markets as placement agents."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-020057","json":"https://secwatch.observer/filing/0001628280-25-020057.json","markdown":"https://secwatch.observer/filing/0001628280-25-020057.md","text":"https://secwatch.observer/filing/0001628280-25-020057.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1567264/000162828025020057/0001628280-25-020057-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1567264/000162828025020057/intensity-20250424.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T05:51:04.907735+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}